AD7c-NTP

11/01/2022 - "The aim of this study was to assess the correlation between serum Aβ1-42, Dnmt3a2, and urinary AD7c-NTP and cognitive dysfunction in MDD. "
01/01/2018 - "This study examined the association between urinary AD7c-NTP and late-life depression with cognitive impairment. "
04/01/2015 - "The aim of this study was to explore the value of urinary AD7c-NTP to assist in the diagnosis of cognitive impairment by comparing differences in urinary AD7c-NTP among normal controls, MCI patients and AD patients. "
12/01/2014 - "To our knowledge this study is the first to show that urine AD7c-NTP level increases with age in a healthy Chinese population without cognitive dysfunction. "
11/01/2022 - "Although urinary AD7c-NTP was closely related to cognitive dysfunction in FEDs, this relationship did not hold in RMDDs."

12/15/1997 - "In vitro studies demonstrated that overexpression of AD7c-NTP in transfected neuronal cells promotes neuritic sprouting and cell death, the two principal neuroanatomical lesions correlated with dementia in AD. "
01/01/2002 - "In this regard, elevated levels of AD7c-NTP can be detected in both CSF and urine of patients with early or moderately severe AD, and the CSF and urinary levels of AD7c-NTP correlate with the severity of dementia. "
06/01/2001 - "In this regard, elevated levels of AD7c-NTP can be detected in both CSF and urine of patients with early or moderately severe AD, and the CSF and urinary levels of AD7c-NTP correlate with the severity of dementia. "
12/15/1997 - "The results suggest that abnormal AD7c-NTP expression is associated with AD neurodegeneration, and during the early stages of disease, CSF levels correlate with the severity of dementia."
12/15/1997 - "CSF levels of AD7c-NTP were correlated with Blessed dementia scale scores (r = 0. "

01/01/2020 - "AD7c-NTP Impairs Adult Striatal Neurogenesis by Affecting the Biological Function of MeCP2 in APP/PSl Transgenic Mouse Model of Alzheimer's Disease."
01/01/2014 - "Accuracy of urinary AD7c-NTP for diagnosing Alzheimer's disease: a systematic review and meta-analysis."
01/01/1998 - "Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker."
06/03/2014 - "[Diagnostic value of AD7C-NTP for patients with mild cognitive impairment due to Alzheimer's disease]."
07/01/2013 - "A literature review of AD7c-ntp as a biomarker for Alzheimer's disease."

12/15/1997 - "In CSF samples from individuals with early possible or probable AD, the mean concentration of AD7c-NTP (4.6+/-3.4) was also elevated relative to the levels in CSF from age-matched (1.2+/-0.7) and neurological disease (1.0+/-0.9) controls, and ambulatory patients with Parkinson's disease (1.8+/-1.1) (all P < 0.001). "
12/15/1997 - "Ghanbari, manuscript submitted for publication) constructed with antibodies to the recombinant protein, AD7c-NTP levels were measured under code in 323 clinical and postmortem cerebrospinal fluid (CSF) samples from AD, age-matched control, Parkinson's disease, and neurological disease control patients. "
01/01/2023 - "Retracted: Effects of Pramipexole Combined with Nerve Growth Factor on Cognitive Impairment and Urinary AD7c-NTP Expression in Patients with Parkinson's Disease."
01/01/2022 - "Effects of Pramipexole Combined with Nerve Growth Factor on Cognitive Impairment and Urinary AD7c-NTP Expression in Patients with Parkinson's Disease."

01/01/2020 - "Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment."
01/01/2020 - "Urinary AD7c-NTP levels were not related to years of education, nature of work, family history of dementia, a history of hypertension, stroke, anemia, or thyroid dysfunction. "
01/01/2018 - "The urine AD7c-NTP levels exhibited no association with non-neurological diseases (0.3346±0.4482 ng/ml), such as hypertension (0.3445±0.4187), stroke (0.3652±0.4010), diabetes (0.3319±0.4371), dyslipidemia (0.3440±0.4314), renal insufficiency (0.3223±0.3909), cancer (0.5055±1.0006), chronic lung disease (0.2911±0.2852), chronic liver disease (0.5579±0.6726), severe depression symptoms (0.5186±0.7040), and mild depression symptoms (0.3669±0.3811). "